Literature DB >> 33811077

A cytoskeletal function for PBRM1 reading methylated microtubules.

Menuka Karki1, Rahul K Jangid1, Ramakrishnan Anish2, Riyad N H Seervai1,3,4, Jean-Philippe Bertocchio1,5, Takashi Hotta6, Pavlos Msaouel5, Sung Yun Jung2, Sandra L Grimm7, Cristian Coarfa1,3,8, Bernard E Weissman9, Ryoma Ohi6, Kristen J Verhey6, H Courtney Hodges1,3, Warren Burggren10, Ruhee Dere1,3, In Young Park1,3, B V Venkataram Prasad2, W Kimryn Rathmell11, Cheryl L Walker12,3,8,13, Durga N Tripathi12,3.   

Abstract

Epigenetic effectors "read" marks "written" on chromatin to regulate function and fidelity of the genome. Here, we show that this coordinated read-write activity of the epigenetic machinery extends to the cytoskeleton, with PBRM1 in the PBAF chromatin remodeling complex reading microtubule methyl marks written by the SETD2 histone methyltransferase. PBRM1 binds SETD2 methyl marks via BAH domains, recruiting PBAF components to the mitotic spindle. This read-write activity was required for normal mitosis: Loss of SETD2 methylation or pathogenic BAH domain mutations disrupt PBRM1 microtubule binding and PBAF recruitment and cause genomic instability. These data reveal PBRM1 functions beyond chromatin remodeling with domains that allow it to integrate chromatin and cytoskeletal activity via its acetyl-binding BD and methyl-binding BAH domains, respectively. Conserved coordinated activity of the epigenetic machinery on the cytoskeleton opens a previously unknown window into how chromatin remodeler defects can drive disease via both epigenetic and cytoskeletal dysfunction.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33811077     DOI: 10.1126/sciadv.abf2866

Source DB:  PubMed          Journal:  Sci Adv        ISSN: 2375-2548            Impact factor:   14.957


  5 in total

Review 1.  Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.

Authors:  Daniel Desaulniers; Paule Vasseur; Abigail Jacobs; M Cecilia Aguila; Norman Ertych; Miriam N Jacobs
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

Review 2.  PBRM1, SETD2 and BAP1 - the trinity of 3p in clear cell renal cell carcinoma.

Authors:  Joseph Walton; Keith Lawson; Panagiotis Prinos; Antonio Finelli; Cheryl Arrowsmith; Laurie Ailles
Journal:  Nat Rev Urol       Date:  2022-10-17       Impact factor: 16.430

3.  Mammalian SWI/SNF chromatin remodeler is essential for reductional meiosis in males.

Authors:  Debashish U Menon; Oleksandr Kirsanov; Christopher B Geyer; Terry Magnuson
Journal:  Nat Commun       Date:  2021-11-12       Impact factor: 17.694

4.  Evolutionary conserved relocation of chromatin remodeling complexes to the mitotic apparatus.

Authors:  Giovanni Messina; Yuri Prozzillo; Francesca Delle Monache; Maria Virginia Santopietro; Patrizio Dimitri
Journal:  BMC Biol       Date:  2022-08-03       Impact factor: 7.364

5.  PBRM1 Cooperates with YTHDF2 to Control HIF-1α Protein Translation.

Authors:  Alena Shmakova; Mark Frost; Michael Batie; Niall S Kenneth; Sonia Rocha
Journal:  Cells       Date:  2021-06-08       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.